13F Data
Security · CUSIP 89422GAA5

TRAVERE THERAPEUTICS INC

NOTE 2.250% 3/0 · institutional ownership from 13F filings
13F holders
0
Shares held
0
Value held
$0
New / sold out
0 / 1
Added / reduced
0 / 0
net -2.0K shares

13F holders by quarter

Q1 2022: 3Q2 2022: 2Q3 2022: 4Q4 2022: 4Q1 2023: 2Q2 2023: 2Q3 2023: 2Q4 2023: 3Q1 2024: 3Q2 2024: 3Q3 2024: 3Q4 2024: 5Q1 2025: 2Q2 2025: 4Q3 2025: 4Q4 2025: 5Q1 2026: 2Q2 2026: 0
Q1 2022Q2 2026

Net shares bought by existing holders

Q1 2022: 6.0MQ2 2022: -2.0MQ3 2022: 228.8KQ4 2022: 1.2MQ1 2023: -2.5MQ2 2023: 250.0KQ3 2023: -400.0KQ4 2023: 1.4MQ1 2024: -218.1KQ2 2024: -488.5KQ3 2024: -629.1KQ4 2024: 4.3MQ1 2025: 3.3MQ2 2025: 45.4MQ3 2025: -47.4MQ4 2025: -5.0MQ1 2026: 1.4MQ2 2026: -2.0K
Q1 2022Q2 2026

Top holders · Q2 2026

Nothing to show.

Biggest buyers

Nothing to show.

Biggest sellers

ManagerChangeShares changeChange %
NORTHWESTERN MUTUAL WEALTH MANAGEMENT COSold out-2,000-100.0%